Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats

Q Mao, X Liang, Y Wu, Y Lu - Naunyn-Schmiedeberg's Archives of …, 2019 - Springer
It has been found that use of drugs which upregulate the PI3K/Akt pathway can effectively
reduce cardiomyocyte apoptosis which has been induced by coronary microembolization …

Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.

Q Mao, X Liang, Y Wu, Y Lu - Naunyn-schmiedeberg's Archives of …, 2019 - europepmc.org
It has been found that use of drugs which upregulate the PI3K/Akt pathway can effectively
reduce cardiomyocyte apoptosis which has been induced by coronary microembolization …

Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats

Q Mao, X Liang, Y Wu, Y Lu - … -Schmiedeberg's Archives of …, 2019 - search.proquest.com
It has been found that use of drugs which upregulate the PI3K/Akt pathway can effectively
reduce cardiomyocyte apoptosis which has been induced by coronary microembolization …

Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.

Q Mao, X Liang, Y Wu, Y Lu - 2019 - cabidigitallibrary.org
It has been found that use of drugs which upregulate the PI3K/Akt pathway can effectively
reduce cardiomyocyte apoptosis which has been induced by coronary microembolization …

Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats

Q Mao, X Liang, Y Wu, Y Lu - … -Schmiedeberg's archives of …, 2019 - pubmed.ncbi.nlm.nih.gov
It has been found that use of drugs which upregulate the PI3K/Akt pathway can effectively
reduce cardiomyocyte apoptosis which has been induced by coronary microembolization …